Drug recall · December 18, 2013
Oxcarbazepine Tablets recall
Why: SubPotent Drug: The firm discovered out of specification results for assay and the extended investigation revealed the potential for lower weight tablets.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Oxcarbazepine Tablets, 150 mg, packaged in a) 10 x 10 count Unit-Dose Tablets in blisters packaged in a carton (NDC 0054-0097-20) and b) 100-count bottle (NDC 0054-0097-25), Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216
- Lots / codes
Lot #: a) 259666A, Exp. MAR 2014; b) 259666B, Exp. MAR 2014
- Quantity
- 8,550 cartons and bottles
- Company
- Boehringer Ingelheim Roxane Inc, Columbus, OH
- Distribution
- Nationwide and Puerto Rico
- Initiated
- March 18, 2013 · Voluntary: Firm initiated
- Classified
- December 11, 2013
- Reported
- December 18, 2013
- Ended
- February 12, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxcarbazepine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.